α-Galactosidase Antibody Conjugated to FITC

Product Description

α-Galactosidase Antibody Conjugated to FITC
Catalog number: B2010918
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 50 ug
Molecular Weight or Concentration: na
Supplied as: Solution
Applications: molecular tool for various immuno-applications
Storage: -20C
Keywords: Anti-α Gal Polyclonal Antibody FITC Conjugate
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1: Lenders M, Brand E. Fabry Disease: The Current Treatment Landscape Drugs. 2021 Apr;81(6):635-645.
2: Azevedo O, Gago MF, Miltenberger-Miltenyi G, Sousa N, Cunha D. Fabry Disease Therapy: State-of-the-Art and Current Challenges Int J Mol Sci. 2020 Dec 28;22(1):206.
3: Ros M, Nguyen AT, Chia J, Le Tran S, Le Guezennec X, McDowall R, Vakhrushev S, Clausen H, Humphries MJ, Saltel F, Bard FA. ER-resident oxidoreductases are glycosylated and trafficked to the cell surface to promote matrix degradation by tumour cells Nat Cell Biol. 2020 Nov;22(11):1371-1381.
4: Arends M, Biegstraaten M, Wanner C, Sirrs S, Mehta A, Elliott PM, Oder D, Watkinson OT, Bichet DG, Khan A, Iwanochko M, Vaz FM, van Kuilenburg ABP, West ML, Hughes DA, Hollak CEM. Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort study J Med Genet. 2018 May;55(5):351-358.
5: Farhadi SA, Bracho-Sanchez E, Freeman SL, Keselowsky BG, Hudalla GA. Enzymes as Immunotherapeutics Bioconjug Chem. 2018 Mar 21;29(3):649-656.
6: Kukacka Z, Iurascu M, Lupu L, Rusche H, Murphy M, Altamore L, Borri F, Maeser S, Papini AM, Hennermann J, Przybylski M. Antibody Epitope of Human α-Galactosidase A Revealed by Affinity Mass Spectrometry: A Basis for Reversing Immunoreactivity in Enzyme Replacement Therapy of Fabry Disease ChemMedChem. 2018 May 8;13(9):909-915.
7: Lenders M, Brand E. Precision medicine in Fabry disease Nephrol Dial Transplant. 2021 Jun 22;36(Suppl 2):14-23.
8: Bargh JD , Walsh SJ , Ashman N , Isidro-Llobet A , Carroll JS , Spring DR . A dual-enzyme cleavable linker for antibody-drug conjugates Chem Commun (Camb). 2021 Apr 11;57(28):3457-3460.
9: Su Z, Gao J, Xie Q, Wang Y, Li Y. Possible role of β-galactosidase in rheumatoid arthritis Mod Rheumatol. 2020 Jul;30(4):671-680.
10: Feriozzi S, Hughes DA. New drugs for the treatment of Anderson-Fabry disease J Nephrol. 2021 Feb;34(1):221-230.

Products Related to α-Galactosidase Antibody Conjugated to FITC: Conjugates